Xinling Pharmaceutical is an innovative transdermal preparation platform company.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 18, 2022 | Seed | ¥100M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
China Science and Technology Innovation | — | Seed |